Inogen (INGN) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | -9.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.83% |
| Dec 31, 2025 | -5.63% |
| Sep 30, 2025 | -2.78% |
| Jun 30, 2025 | -0.20% |
| Mar 31, 2025 | 1.48% |
| Dec 31, 2024 | 4.48% |
| Sep 30, 2024 | 7.93% |
| Jun 30, 2024 | 11.38% |
| Mar 31, 2024 | 16.63% |
| Dec 31, 2023 | 21.25% |
| Sep 30, 2023 | 25.06% |
| Mar 31, 2023 | 32.69% |
| Dec 31, 2022 | 30.57% |
| Sep 30, 2022 | 26.89% |
| Jun 30, 2022 | 23.69% |
| Mar 31, 2022 | 21.37% |
| Dec 31, 2021 | 20.33% |
| Sep 30, 2021 | 17.22% |
| Jun 30, 2021 | 15.70% |
| Mar 31, 2021 | 14.11% |
| Dec 31, 2020 | 11.98% |
| Sep 30, 2020 | 6.52% |
| Mar 31, 2020 | -6.16% |
| Dec 31, 2019 | -8.29% |
| Sep 30, 2019 | -9.50% |
| Jun 30, 2019 | -9.10% |
| Mar 31, 2019 | -9.47% |
| Dec 31, 2018 | -10.03% |
| Sep 30, 2018 | -10.13% |
| Jun 30, 2018 | -11.94% |
| Mar 31, 2018 | -25.79% |
| Dec 31, 2017 | -14.29% |
| Sep 30, 2017 | -22.80% |
| Jun 30, 2017 | -19.98% |
| Mar 31, 2017 | -7.25% |
| Dec 31, 2016 | -12.47% |